EML4-RET fusion
|
NSCLC
|
EML4-RET fusion
|
NSCLC
|
pralsetinib Sensitive: D – Preclinical
|
pralsetinib Sensitive: D – Preclinical
|
EML4-RET fusion
|
NSCLC
|
EML4-RET fusion
|
NSCLC
|
RXDX-105 Sensitive: D – Preclinical
|
RXDX-105 Sensitive: D – Preclinical
|